# US 2016/0251664 A1 · Methods and compositions for synthesis of nucleic acid molecules using multiplerecognition sites

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251664 A1
- Document ID: US20160251664A1
- Status: Published application
- Kind: A1
- Application number: 15/060,536
- Filed: 2016-03-03
- Published: 2016-09-01
- Earliest claimed: 2000-12-11
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Jonathan Chesnut; John Carrino; Louis Leong; Knut Madden; Matin Gleeson; James Fan; Michael Brasch; David Cheo; James Hartley; Devon Byrd; Gary Temple
- Web page: https://patentgrep.com/patent/US20160251664A1

## CPC

- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N 9/90: Isomerases (5.)
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/64: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C12N 15/902: {using homologous recombination}
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 2800/108: episomal vectors
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N 2800/70: Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
- C12N 2840/20: translation of more than one cistron
- C12Y 599/01: Other isomerases (5.99.1)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. The invention also provides host cells comprising nucleic acid molecules of the invention or prepared according to the methods of the invention, and also provides kits comprising the compositions, host cells and nucleic acid molecules of the invention, which may be used to synthesize nucleic acid molecules according to the methods of the invention.

## Claims

### Claim 1

An isolated nucleic acid molecule comprising: (a) one or more recombination sites; and (b) one or more topoisomerase recognition sites and/or one or more topoisomerases.

### Claim 2 (depends on 1)

The nucleic acid molecule of claim 1, wherein said nucleic acid molecule is a circular molecule.

### Claim 3 (depends on 1)

The nucleic acid molecule of claim 1, wherein said nucleic acid molecule comprises two or more recombination sites.

### Claim 4 (depends on 1)

The nucleic acid molecule of claim 1, wherein said recombination sites are selected from the group consisting of:
(a) attB sites,
(b) attP sites,
(c) attL sites,
(d) attR sites,
(e) lox sites,
(f) psi sites,
(g) dif sites,
(h) cer sites,
(i) frt sites,
and mutants, variants, and derivatives of the recombination sites of (a), (b), (c), (d), (e), (f), (g), (h) or (i) which retain the ability to undergo recombination.

### Claim 5 (depends on 1)

The nucleic acid molecule of claim 1, wherein said topoisomerase recognition site is recognized and bound by a type I topoisomerase.

### Claim 6 (depends on 5)

The nucleic acid molecule of claim 5, wherein said type I topoisomerase is a type IB topoisomerase.

### Claim 7

An in vitro method of cloning a nucleic acid molecule comprising:
(a) obtaining a first nucleic acid molecule to be cloned;
(b) mixing said first nucleic acid molecule to be cloned in vitro with a second nucleic acid molecule comprising at least a first topoisomerase recognition site flanked by at least a first recombination site, and at least a second topoisomerase recognition site flanked by at least a second recombination site, wherein said first and second recombination sites do not recombine with each other, and at least one topoisomerase; and
(c) incubating said mixture under conditions such that said first nucleic acid molecule to be cloned is inserted into said second nucleic acid molecule between said first and second topoisomerase recognition sites, thereby producing a first product molecule comprising said first nucleic acid molecule to be cloned between said first and second recombination sites.

### Claim 8 (depends on 7)

The method of claim 7, wherein the second nucleic acid molecule is a vector.

### Claim 9 (depends on 7)

The method of claim 7, wherein said first nucleic acid molecule to be cloned is a linear nucleic acid molecule.

### Claim 10 (depends on 7)

The method of claim 7, further comprising contacting said first product molecule with at least one third nucleic acid molecule comprising at least a third and fourth recombination sites that do not recombine with each other, under conditions favoring recombination between said first and third and between said second and fourth recombination sites, thereby producing at least one second product molecule.

### Claim 11 (depends on 10)

The method of claim 10, wherein the third nucleic acid molecule is a vector.

### Claim 12 (depends on 7)

The method of claim 7, wherein said second nucleic acid molecule comprises at least one additional nucleic acid sequence selected from the group consisting of a selectable marker, a cloning site, a restriction site, a promoter, an operator, an operon, an origin of replication, and a gene or partial gene.

### Claim 13 (depends on 10)

The method of claim 10, wherein said third nucleic acid molecule comprises at least one additional nucleic acid sequence selected from the group consisting of a selectable marker, a cloning site, a restriction site, a promoter, an operator, an operon, an origin of replication, and a gene or partial gene.

### Claim 14 (depends on 7)

The method of claim 7, wherein said first and second recombination sites are selected from the group consisting of:
(a) attB sites,
(b) attP sites,
(c) attL sites,
(d) attR sites,
(e) lox sites,
(f) psi sites,
(g) dif sites,
(h) cer sites,
(i) frt sites,
and mutants, variants, and derivatives of the recombination sites of (a), (b), (c), (d), (e), (f), (g), (h) or (i) which retain the ability to undergo recombination.

### Claim 15 (depends on 10)

The method of claim 10, wherein said third and fourth recombination sites are selected from the group consisting of:
(a) attB sites,
(b) attP sites,
(c) attL sites,
(d) attR sites,
(e) lox sites,
(f) psi sites,
(g) dif sites,
(h) cer sites,
(i) frt sites,
and mutants, variants, and derivatives of the recombination sites of (a), (b), (c), (d), (e), (f), (g), (h) or (i) which retain the ability to undergo recombination.

### Claim 16 (depends on 7)

The method of claim 7, wherein said topoisomerase is a type I topoisomerase.

### Claim 17 (depends on 16)

The nucleic acid molecule of claim 16, wherein said type I topoisomerase is a type IB topoisomerase.

### Claim 18 (depends on 10)

The method of claim 10, wherein said product nucleic acid molecule and said third nucleic acid molecule are combined in the presence of at least one recombination protein.

### Claim 19 (depends on 18)

The method of claim 18, wherein said recombination protein is selected from the group consisting of:
(a) Cre;
(b) Int;
(c) IHF;
(d) X is;
(e) F is;
(f) Hin;
(g) Gin;
(h) Cin;
(i) Tn3 resolvase;
(j) TndX;
(k) XerC; and
(l) XerD.

### Claim 20 (depends on 1)

A kit comprising the isolated nucleic acid molecule of claim 1.
